Are you looking for expert advice...

As part of our work to support the prescribing of medical cannabis for children living with treatment-resistant epilepsy, the Medical Cannabis Clinicians Society has developed an expert panel to provide multi-disciplinary guidance to anonymised individual cases presented by prescribing UK physicians.

Led by Professor Mike Barnes, Chair of The Medical Cannabis Clinicians Society, the Resistant Epilepsy Cannabis Assessment Panel (RECAP) is made up of national cannabis experts, all members of the Society’s expert committee. It is supported by international paediatric neurologists with specialisation in the treatment of epilepsy.

Purple ribbon for epilepsy

Objectives of the RECAP Panel

  1. Reduce harm by reducing the impact of unguided care. Some patients are using black market products without clinical oversight, and others are directed to surgery before being given the opportunity to consider medical cannabis.
  2. Support doctors with an independent pathway to procure guidance from their peers with global expertise and clinical experience regarding medical cannabis and epilepsy treatments.
  3. Collect real-world evidence through anonymised data regarding medical cannabis treatment to inform future therapeutic benefit and regulatory procedure.

How the Panel works

  1. The Clinician decides a patient may benefit from medical cannabis treatment and begins to explore options
  2. They contact the Society via email to arrange an appointment with RECAP through Zoom.
  3. The Clinician will complete a short form to provide RECAP with the necessary anonymised information about the patient.
  4. RECAP members will review the case independently, then as a team, before meeting with the prescribing Clinician to discuss the case and provide peer support. This meeting will take place within seven working days of the Clinician’s enquiry, wherever possible.

If you are a paediatrician wishing to prescribe medical cannabis for a patient and need support, email [email protected] to arrange.

News

News, case studies, clinician profiles and patient stories from the Medical Cannabis Clinicians Society.

Patient Stories

Patient Stories

Hear from patients benefiting from medical cannabis treatments in the UK.

Join the MCCS

Join the MCCS

Key reasons to join MCCS, a supportive clinical community growing by the day. Exclusive prescribing information, product details and peer support.

New: Good Practice Guide for Prescribers of CBPMs
June 14, 2024

New: Good Practice Guide for Prescribers of CBPMs

Since the legalisation of cannabis-based medicinal products (CBPMs) in the UK in November 2018, around 40,000 patients have received these treatments, with numbers steadily increasing. There are currently 40 clinics…

Essential Insights on the Endocannabinoidome
June 14, 2024

Essential Insights on the Endocannabinoidome

As part of our commitment to keeping healthcare professionals at the forefront of medical cannabis knowledge, we are pleased to give you access to a detailed webinar and a new research…

Elevate Your Private Practice: Joining Script Assist’s Find A Doctor
March 8, 2024

Elevate Your Private Practice: Joining Script Assist’s Find A Doctor

As clinicians committed to the advancement of medical cannabis treatment, staying at the forefront of patient care is a constant pursuit. The Society (MCCS) champions the integration of medical cannabis…

Discover CT-Cann2024: Leading the Way in Medical Cannabis
February 2, 2024

Discover CT-Cann2024: Leading the Way in Medical Cannabis

The Medical Cannabis Clinicians Society (MCCS) is excited to support an essential event in the world of medical cannabis – the International Conference on the Science & Practice of Medical…